WebDisclosure WebDisclosure
Basculer en Français
11115 Companies
244653 Keywords
172682 Articles
131850 Press releases
Headlines Articles Press releases Hansoh Pharma Remove
  1. Home
  2. Companies
  3. Hansoh Pharma
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/02/2026 at 06:10, 1 hour 46 minutes ago

    Hansoh Pharma's Olatorepatide Shows Promise in Weight Loss Study

    Weight Loss Phase III Study Olatorepatide GLP-1/GIP Agonist Hansoh Pharma
  • BRIEF

    published on 10/02/2026 at 06:10, 1 hour 46 minutes ago

    L'olatorépatide de Hansoh Pharma se révèle prometteur dans une étude sur la perte de poids

    Perte De Poids Étude De Phase III Olatorepatide Hansoh Pharma Agoniste Du GLP-1/GIP
  • PRESS RELEASE

    published on 10/02/2026 at 06:05, 1 hour 51 minutes ago

    19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD

    Phase III data of Hansoh Pharma's Olatorepatide, a dual-biased GLP-1/GIP agonist, showing 19.3% weight loss efficacy at Week 48 presented at EASD. Study demonstrates significant weight loss benefits and metabolic improvements
    Weight Loss Olatorepatide GLP-1/GIP Agonist Hansoh Pharma EASD
    Logo of Hansoh Pharma
Accesswire
  • Published on 10/02/2026 at 04:15, 3 hours 42 minutes ago

    Torq Completes $529,000 Debt Settlement

  • Published on 10/02/2026 at 00:35, 7 hours 22 minutes ago

    Medicure Announces Grant of Stock Options

  • Published on 10/02/2026 at 00:30, 7 hours 27 minutes ago

    Immutable Holdings Provides Corporate Update

  • Published on 10/01/2026 at 23:05, 8 hours 52 minutes ago

    Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team

  • Published on 10/01/2026 at 22:00, 9 hours 57 minutes ago

    Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos

View all ACCESSWIRE
EQS Group
  • Published on 10/02/2026 at 07:30, 26 minutes ago

    Partners Group evolves established private equity evergreen strategy to offer greater investor flexibility

  • Published on 10/02/2026 at 07:00, 56 minutes ago

    Julius Baer announces CHF 600 million share buy-back and revised capital distribution policy

  • Published on 10/02/2026 at 06:33, 1 hour 24 minutes ago

    MHM CORPORATE — 2026 Half-Year Results and Publication of the Half-Year Financial Report

  • Published on 10/02/2026 at 06:33, 1 hour 24 minutes ago

    MHM CORPORATE — Résultats semestriels 2026 et publication du rapport financier semestriel

  • Published on 10/02/2026 at 06:20, 1 hour 36 minutes ago

    Le prix des carburants renforce la demande de voitures électriques – plus d'une auto sur trois vendue en septembre est une BEV

View all EQS
Les Echos
  • Published on 10/01/2026 at 19:00, 12 hours 57 minutes ago

    AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions

  • Published on 10/01/2026 at 19:00, 12 hours 57 minutes ago

    AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye

  • Published on 10/01/2026 at 18:40, 13 hours 16 minutes ago

    Monthly disclosure of the total number of shares and voting rights - September 2026

  • Published on 10/01/2026 at 18:40, 13 hours 16 minutes ago

    TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026

  • Published on 10/01/2026 at 18:07, 13 hours 50 minutes ago

    Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy